Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-107367
Filing Date
2025-08-12
Accepted
2025-08-12 16:22:47
Documents
86
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lyra-20250630.htm   iXBRL 10-Q 3001421
2 EX-10.1 lyra-ex10_1.htm EX-10.1 349439
3 EX-10.2 lyra-ex10_2.htm EX-10.2 29670
4 EX-10.3 lyra-ex10_3.htm EX-10.3 29884
5 EX-10.4 lyra-ex10_4.htm EX-10.4 30865
6 EX-31.1 lyra-ex31_1.htm EX-31.1 17757
7 EX-31.2 lyra-ex31_2.htm EX-31.2 17751
8 EX-32.1 lyra-ex32_1.htm EX-32.1 10123
9 EX-32.2 lyra-ex32_2.htm EX-32.2 10112
  Complete submission text file 0000950170-25-107367.txt   11384423

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lyra-20250630.xsd EX-101.SCH 1409919
89 EXTRACTED XBRL INSTANCE DOCUMENT lyra-20250630_htm.xml XML 1935678
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39273 | Film No.: 251207073
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)